The Minister of Health Canada, Rona Ambrose, recently announced the development of experimental Ebola vaccine, developed in the country, has been successful in tests conducted with primates; so it will initiate a clinical examination phase for humans in the United States, published the digital portal of Telesur. The vaccine, which will be applied to healthy individuals to observe their performance and, especially, to discover if you have side effects and determine the appropriate dose for your application may be sent to West Africa in a few months if positive achievements of the experimental strain was obtained. We are likely to share with very promising news in the fight against Ebola, said Ambrose, who also said that by December of this year the results of the first phase of the tests are expected. The health portfolio holder explained that the drug was developed by scientists at the National Microbiology Laboratory, under the Public Health Agency of Canada. In their statements, Ambrose also revealed that the strain will be provided to 20 volunteers at the Institute of Research Walter Reed Army in the town of Silver Spring, Maryland, the eastern United States, for the initiation of clinical trials.
Posted on: Thu, 16 Oct 2014 08:14:29 +0000
Trending Topics
Recently Viewed Topics
© 2015